Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances
Type 2 immunity has long been confined to a restricted spectrum of responses, mostly including allergic reactions to innocuous environmental triggers. However, growing evidence suggests that cells and mediators typically associated with type 2 inflammation are involved in several physiopathological...
Saved in:
Main Author: | Massimo Costanza |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/4204512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroborreliosis mimicking demyelinating disease of the central nervous system: case reports
by: N. Giedraitienė, et al.
Published: (2018-09-01) -
Local Overexpression of Interleukin-11 in the Central Nervous System Limits Demyelination and Enhances Remyelination
by: Anurag Maheshwari, et al.
Published: (2013-01-01) -
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01) -
The impact of gut microbiome on neuro-autoimmune demyelinating diseases
by: Pouria Abolfazli, et al.
Published: (2024-10-01) -
Recent Advances in Carbon Nanotubes for Nervous Tissue Regeneration
by: Carlos Redondo-Gómez, et al.
Published: (2020-01-01)